Qualigen, Inc.

Jun 02, 2020

Qualigen Therapeutics Releases FastPack® SARS-CoV-2 Antibody Diagnostic Test to University of Louisville to Conduct Validation Studies

Feb 04, 2020

Qualigen Announces New U.S. Patent Issued for its FastPack® Diagnostic Technology

Apr 11, 2019

Qualigen Enters into Research Agreement for RAS Inhibitor Cancer Drug with University of Louisville (UofL)

Nov 28, 2018

Qualigen Announces New Patent Issued for its FastPack® 2.0 System in China

Oct 09, 2018

Qualigen Files a 510(k) Submission with the FDA for Its FastPack® IP SHBG Assay

Oct 04, 2018

Qualigen Announces New Patent Issued for its FastPack® Diagnostic Technology in China

Sep 06, 2018

Ronald S. Musich joins Qualigen's Board of Directors

Jul 12, 2018

Qualigen in-licenses novel cancer drug from University of Louisville (UofL)

Jul 06, 2017

Kurt H. Kruger joins Qualigen's Board of Directors

Jul 06, 2017

Richard David, MD, FACS joins Qualigen's Board of Directors